Clincosm LogoSign in Get a demo

primary peritoneal carcinoma

Showing 1 - 25 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting
  • High Grade Serous Adenocarcinoma of Ovary
  • +3 more
  • (no location specified)
Oct 13, 2023

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +13 more
  • (no location specified)
Mar 29, 2023

Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

Recruiting
  • Ovarian Cancer
  • +8 more
  • Scottsdale, Arizona
  • +11 more
Jan 31, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Chicago, Providence (Nivolumab, Ipilimumab)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Chicago, Illinois
  • +3 more
Jan 26, 2023

Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma Trial (ONC-392, Pembrolizumab)

Recruiting
  • Ovarian Cancer
  • +3 more
  • Goodyear, Arizona
  • +19 more
Dec 26, 2022

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Australia (ATX-101 + Carboplatin + Pegylated

Recruiting
  • Ovarian Cancer
  • +3 more
  • ATX-101 + Carboplatin + Pegylated liposomal doxorubicin (ACD)
  • Blacktown, New South Wales, Australia
  • +5 more
Nov 9, 2022

Tumor, Ovarian, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer Trial (AVB-001 (Dose Escalation Phase), AVB-001 (Dose

Not yet recruiting
  • Neoplasm, Ovarian
  • +7 more
  • AVB-001 (Dose Escalation Phase)
  • AVB-001 (Dose Expansion Phase)
  • (no location specified)
Sep 15, 2022

Investigate Adaptation and Evolution of Ovarian High-grade

Recruiting
  • Ovarian Cancer
  • +6 more
    • Bristol, United Kingdom
    • +10 more
    Sep 8, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Philadelphia (MOv19-BBz CAR T cells, Alpha Folate

    Recruiting
    • Ovarian Cancer
    • +2 more
    • MOv19-BBz CAR T cells
    • Alpha Folate Receptor expression test
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Sep 12, 2022

    Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

    Recruiting
    • Stage III Ovarian Cancer
    • +6 more
    • Cytoreductive Surgery (CRS)
    • +6 more
    • Baltimore, Maryland
      Mercy Medical Center
    Aug 30, 2022

    Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,

    Recruiting
    • Breast Carcinoma
    • +7 more
    • Computed Tomography
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 24, 2022

    Patients With Low Grade Ovarian or Peritoneal Tumors

    Recruiting
    • Low Grade Ovarian Serous Adenocarcinoma
    • +5 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in United States (STRO-002, Bevacizumab)

    Recruiting
    • Ovarian Cancer
    • +4 more
    • Tampa, Florida
    • +5 more
    Aug 1, 2022

    Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

    Not yet recruiting
    • Platinum-resistant Ovarian Cancer
    • +6 more
    • Pegylated Liposomal Doxorubicin + SL-172154
    • Mirvetuximab + SL-172154
    • (no location specified)
    Jul 29, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in Santa Monica, Pittsburgh, Houston (TTI-622, Pegylated Liposomal

    Recruiting
    • Ovarian Cancer
    • +5 more
    • TTI-622
    • Pegylated Liposomal Doxorubicin
    • Santa Monica, California
    • +4 more
    Jul 26, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (3 cycles chemo instead of 6 cycles chemo, 6 cycles

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • 3 cycles chemotherapy instead of 6 cycles chemotherapy
    • 6 cycles chemotherapy
    • (no location specified)
    Jul 12, 2022

    Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer Trial in United States (Mind-body resilience training, Music therapy,

    Recruiting
    • Ovarian Cancer
    • +13 more
    • Mind-body resilience training
    • +3 more
    • Basking Ridge, New Jersey
    • +6 more
    Jun 28, 2022

    Factors Influencing Cascade Testing Among Hereditary

    Recruiting
    • Breast Carcinoma
    • +8 more
    • Interview
    • +2 more
    • Birmingham, Alabama
    • +1 more
    Jun 22, 2022

    Peritoneal Cancer, Pseudomyxoma Peritonei, Mucinous Adenocarcinoma Trial in Lexington, Stony Brook (nanoliposomal irinotecan)

    Completed
    • Peritoneal Cancer
    • +7 more
    • nanoliposomal irinotecan
    • Lexington, Kentucky
    • +1 more
    May 5, 2022

    Stage III Ovarian Carcinoma, Stage IV Ovarian Carcinoma, Fallopian Tube Carcinoma Trial in United States (AVOVA-1, MC)

    Active, not recruiting
    • Stage III Ovarian Carcinoma
    • +3 more
    • AVOVA-1
    • MC
    • Burbank, California
    • +5 more
    Apr 21, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Beijing (Fluzoparib; Apatinib, Fluzoparib, Placebo)

    Active, not recruiting
    • Ovarian Cancer
    • +2 more
    • Fluzoparib; Apatinib
    • +2 more
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Apr 22, 2022

    Fallopian Tube Carcinoma, Recurrent Ovarian Cancer, Primary Peritoneal Carcinoma Trial in Columbus (Lenvatinib Mesylate,

    Completed
    • Fallopian Tube Carcinoma
    • +3 more
    • Lenvatinib Mesylate
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 5, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinosarcoma Trial in Germany, United Kingdom (Paclitaxel, TAK228)

    Active, not recruiting
    • Ovarian Cancer
    • +9 more
    • Berlin, Germany
    • +14 more
    Mar 10, 2022